A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis

• Protocol code: PVT-2201-303
• EudraCT code: No aplica
• Research group: Ophtalmology
• Service: Ophthalmology
• Principal investigator:  Kirkegaard Biosca, Eric
• Pathology: Malalties de l’ull i dels seus annexos
• Phase: Fase III